New insights into T and B cells offer hope for autoimmune disease sufferers
Scientists should focus on the interactions between T and B cells to find better treatments for autoimmune disorders, such as rheumatoid arthritis, according to a new study from the University of Surrey.
Systems Biology researchers have found that our metabolism could play an outsized role in the delicate balancing act between T and B cells, leading to autoimmune diseases. The study also found evidence that changes in metabolism caused by ageing add further risks.
T and B cells are specialised white blood cells that play crucial roles in our immune system. T cells help identify and attack infected cells, while B cells create antibodies to neutralise harmful invaders like viruses and bacteria. Through mutual regulation, T and B cells can meet the metabolic demand required in each stage of their development.
The team conducted a thorough critical analysis of the current literature in different areas, such as inflammation and immunometabolism, to comprehensively understand the processes involved, where metabolic, signalling and epigenetic routes integrate.
The study has been published in Clinical and Translational Medicine.
Notes to editors
- Dr Matteo Barberis is available for interview upon request.
- For more information, please get in touch with the University of Surrey's press office via mediarelations@surrey.ac.uk.
Media Contacts
External Communications and PR team
Phone: +44 (0)1483 684380 / 688914 / 684378
Email: mediarelations@surrey.ac.uk
Out of hours: +44 (0)7773 479911